As of January 22, 2025, Okyo Pharma (OKYO) has a market cap of $35.065 million USD. According to our data, Okyo Pharma is ranked No.8350 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $35.06 M |
-9.89%
|
Dec 31, 2024 | $38.91 M |
-35.03%
|
Dec 29, 2023 | $59.89 M |
-7.33%
|
Dec 30, 2022 | $64.63 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Santen Pharmaceutical
4536.T
|
$3.40 B |
-0.000 M
|
Japan
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
Kala Pharmaceuticals
KALA
|
$36.53 M |
0.000 M
|
USA
|
Market Cap | = | OKYO Stock Price | * | OKYO Shares Outstanding |
= | $1.04 | * | 33.84 M | |
= | $35.06 M |